Currently out of the existing stock ratings of Eric Le Berrigaud, 9 are a HOLD (26.47%), 25 are a BUY (73.53%).

Eric Le Berrigaud

Work Performance Price Targets & Ratings Chart

Analyst Eric Le Berrigaud, currently employed at STIFEL, has had 42.86% of price targets met with an average potential upside of 9.72%, reached in 193 days on average. Previously, Eric Le Berrigaud worked at BRYAN GARNIER.

Eric Le Berrigaud has documented 57 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on NVO, at 28-Dec-2024.

Wall Street Analyst Eric Le Berrigaud

Analyst best performing recommendations are on NVO.
The best stock recommendation documented was for NVO on 2/28/2022. The price target of $53.34 was fulfilled within 38 days with a profit of $7.44 (16.21%), with a performance score of 4.27.

Average potential price target upside

  • of $55.62 (16.86%) on RH.
  • of $25.03 (30.83%) on NVS.
  • of $16.44 (20.35%) on NVO.
SNY NVS AZN AstraZeneca PLC ADR GSK GlaxoSmithKline PLC ADR NVO RHHBY IP International Paper RH

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-May-2026

$58

6 months 15 days ago
(01-May-2026)

1/9 (11.11%)

$11.2 (23.93%)

224

Buy Since 17-Aug-2023

$50

$10.08 (25.25%)

6 months 24 days ago
(23-Apr-2026)

0/3 (0%)

$4.97 (11.04%)

Hold Since 13-Apr-2026

$65

7 months 3 days ago
(13-Apr-2026)

1/3 (33.33%)

$18.16 (38.77%)

3248

Hold Since 31-Jul-2017

$57

$8.63 (17.84%)

$57

10 months 17 days ago
(30-Dec-2025)

2/6 (33.33%)

$10.82 (23.43%)

2160

Buy Since 30-Oct-2023

10 months 28 days ago
(19-Dec-2025)

0/3 (0%)

$16.47 (41.66%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Eric Le Berrigaud?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?